Yijie Qiu

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Plaque-Hepatic Targeting Nanotherapy Disrupts the PCSK9-LOX-1 Axis to Suppress oxLDL in Atherosclerosis.

Plaque-Hepatic Targeting Nanotherapy Disrupts the PCSK9-LOX-1 Axis to Suppress oxLDL in Atherosclerosis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 29, 2026

Quantitative liver ultrasound: current status and challenges.

Quantitative liver ultrasound: current status and challenges.

Journal: Ultrasonography (Seoul, Korea)

Published: April 20, 2026

Biomimetic nanozyme reverse the Warburg effect to empower intrahepatic cholangiocarcinoma immunotherapy.

Biomimetic nanozyme reverse the Warburg effect to empower intrahepatic cholangiocarcinoma immunotherapy.

Journal: Biomaterials

Published: January 13, 2026

Diagnostic performance of ultrasound-derived fat fraction for assessing steatotic liver disease with histopathology as the reference.

Diagnostic performance of ultrasound-derived fat fraction for assessing steatotic liver disease with histopathology as the reference.

Journal: Ultrasonography (Seoul, Korea)

Published: August 20, 2025

Ultrasonic radio frequency signals-based hepatorenal index improved the diagnostic performance in steatotic liver disease.

Ultrasonic radio frequency signals-based hepatorenal index improved the diagnostic performance in steatotic liver disease.

Journal: Abdominal radiology (New York)

Published: June 12, 2025

Quantitative ultrasound-derived fat fraction for identifying pediatric patients with metabolic dysfunction-associated steatotic liver disease: a prospective study.

Quantitative ultrasound-derived fat fraction for identifying pediatric patients with metabolic dysfunction-associated steatotic liver disease: a prospective study.

Journal: Pediatric radiology

Published: April 14, 2025

A therapeutic strategy integrating ultrasound-guided microwave ablation with nanocomposite hydrogels to enhance autophagy and suppress tumor growth in hepatocellular carcinoma.

A therapeutic strategy integrating ultrasound-guided microwave ablation with nanocomposite hydrogels to enhance autophagy and suppress tumor growth in hepatocellular carcinoma.

Journal: Acta biomaterialia

Published: January 21, 2025

Mitochondria targeted drug delivery system overcoming drug resistance in intrahepatic cholangiocarcinoma by reprogramming lipid metabolism.

Mitochondria targeted drug delivery system overcoming drug resistance in intrahepatic cholangiocarcinoma by reprogramming lipid metabolism.

Journal: Biomaterials

Published: April 08, 2024

Contrast-enhanced ultrasound features of hepatic sarcomatoid carcinoma different from hepatocellular carcinoma.

Contrast-enhanced ultrasound features of hepatic sarcomatoid carcinoma different from hepatocellular carcinoma.

Journal: Clinical hemorheology and microcirculation

Published: December 31, 2023

Nano Ultrasound Contrast Agent for Synergistic Chemo-photothermal Therapy and Enhanced Immunotherapy Against Liver Cancer and Metastasis.

Nano Ultrasound Contrast Agent for Synergistic Chemo-photothermal Therapy and Enhanced Immunotherapy Against Liver Cancer and Metastasis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 08, 2023

VueBox® perfusion analysis of dynamic contrast enhanced ultrasound provides added value in the diagnosis of small thyroid nodules.

VueBox® perfusion analysis of dynamic contrast enhanced ultrasound provides added value in the diagnosis of small thyroid nodules.

Journal: Clinical hemorheology and microcirculation

Published: January 23, 2023

Ultrasound features of abdominal thrombosis in COVID 19 patients.

Ultrasound features of abdominal thrombosis in COVID 19 patients.

Journal: Clinical hemorheology and microcirculation

Published: July 11, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026